Related Experiment Video
Updated: Nov 2, 2025

06:02
Production of siRNA-Loaded Lipid Nanoparticles using a Microfluidic Device
Published on: March 22, 2022
9.7K
Cationic lipid nanoparticle production by microfluidization for siRNA delivery
Xiaojing Liu1, Badr Bahloul2, René Lai Kuen3
1Université de Paris, UTCBS, CNRS, INSERM, F-75006 Paris, France.
International Journal of Pharmaceutics
|June 7, 2021
Summary
Microfluidization offers a scalable method for creating cationic lipid nanoparticles for short interfering RNA (siRNA) delivery. Optimized parameters yielded stable nanoparticles with high siRNA association, though gene silencing requires further enhancement.
Area of Science:
- Biotechnology
- Nanotechnology
- Drug Delivery
Background:
- Cationic lipid nanoparticles (CLNs) are crucial for delivering nucleic acids like short interfering RNAs (siRNAs).
- Traditional methods for CLN production can be inefficient and difficult to scale.
- Microfluidization presents a promising alternative for scalable CLN synthesis.
Purpose of the Study:
- To optimize the microfluidization process for producing CLNs for siRNA delivery.
- To characterize the physicochemical properties of the resulting CLNs and siRNA-lipoplexes.
- To evaluate the stability and gene silencing efficacy of the optimized CLNs.
Main Methods:
- Design of Experiments (DoE) was employed to optimize microfluidization parameters.
- Key parameters included microfluidization passages (3) and pressure (10,000 psi).
- Thin film hydration volume (4 mL) and charge ratio (+/- 8) were critical for lipoplex formation.
Main Results:
- Optimized microfluidization produced CLNs with a mean size of 160 nm and a polydispersity index of 0.2-0.3.
- The CLNs exhibited a zeta potential of +40 mV to +60 mV.
- At a (+/-) charge ratio of 8, 88% of siRNA was associated with stable lipoplexes for one month.
Conclusions:
- Microfluidization is an effective, scalable method for producing CLNs for siRNA delivery.
- Optimized parameters yield CLNs with desirable size, charge, and high siRNA encapsulation.
- Further optimization is needed to enhance the gene silencing efficacy and reduce cytotoxicity of the lipoplexes.

